AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Mirahype 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Fibovil Pharmaceuticals Pvt Ltd

Salt Composition

Mirabegron (25mg)

Overview Mirahype 25mg Tablet ER

Oxybutynin extended-release 25mg tablets manage overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urinary storage capacity. Dosage and duration should strictly follow your physician's instructions. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report persistent or bothersome side effects to your doctor immediately. Prior to treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.

Uses of Mirahype 25mg Tablet ER

Managing overactive bladder (OAB) symptoms

Major Benefits of Mirahype 25mg Tablet ER:

Consume Mirahype 25mg Extended-Release Tablets precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While this medication can be taken with or without food, consistent daily timing is recommended for optimal efficacy.

Common Side effects of Mirahype 25mg Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Mirahype 25mg Tablet ER:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirahype 25mg Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

How Mirahype 25mg Tablet ER works:

Extended-release Mirahype 25mg tablets contain a beta-3 agonist that acts on bladder receptors. This activation promotes relaxation of the bladder muscles, thereby reducing urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining Mirahype 25mg Extended-Release Tablets with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mirahype 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mirahype 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mirahype 25mg Extended-Release Tablets.

KidneyKidneyCAUTION

Extended-release Mirahype 25mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification of Mirahype 25mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Mirahype 25mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Mirahype 25mg Extended-Release Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Mirahype 25mg Tablet ER :

Should you forget to take your Mirahype 25mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mirahype 25mg Tablet ER

LabelValue
Chemical Type Anilide-based Compound
Developing Habits No.
Treatment Category Urological Care
Actions Beta-3 agonist for bladder control

FAQs on Mirahype 25mg Tablet ER

Mirahype 25mg Tablet ER's full benefits may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4 to 8 weeks, depending on individual response.
Continue taking your Mirahype 25mg Tablet ER, even if your symptoms improve. This medication manages overactive bladder symptoms—urgency, frequency, and incontinence—but doesn't cure the condition. Stopping treatment could cause your symptoms to return.
Mirahype 25mg Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep problems you experience.
Mirahype 25mg Tablet ER should not be given to children under 18 as its safety and efficacy in this age group haven't been established.
Daily use, as prescribed, is essential. This medication manages your condition, it doesn't cure it. Inconsistent use prevents your bladder from adapting fully, leading to symptom recurrence.
Mirahype 25mg ER tablets may cause infections of the kidneys, ureters, bladder, or urethra, though this is not universal. Renal stones and bladder pain are rare reported side effects. Patients with impaired kidney function should use caution and promptly report any kidney-related symptoms to their doctor.
Caution is advised when taking Mirahype 25mg Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as this medication may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of how you feel. A Mirahype 25mg Tablet ER overdose can raise your heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Mirahype 25mg Tablet ER
205
MRP 250
18% off